Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with PMDD (premenstrual dysphoric disorder) according to standard diagnostic guidelines
- Your menstrual cycle is between 23 and 34 days long, meaning you have had 5 to 8 cycles in the last six months
- You can read and understand Swedish well enough to follow the treatment materials
- You have access to a computer, tablet, or mobile phone with an internet connection
Who may not be able to join:
- You are currently breastfeeding or have been pregnant in the last three months
- You have started or changed a prescription for antidepressants, benzodiazepines, contraceptives, or hormone treatments in the last three months
- You have a current or past gynaecological condition, such as endometriosis or polycystic ovary syndrome (PCOS), that could affect the study results (confirm with trial site)
- You have previously received or are currently receiving psychological treatment specifically for premenstrual disorders
- You have a serious mental health condition, such as psychosis, bipolar disorder, severe eating disorder, or severe depression, that could affect your ability to complete the treatment or affect the study results
- You are considered to be at high risk of suicide, for example due to repeated thoughts of suicide, current plans of suicide, or a previous suicide attempt
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +46735252205
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Group differences in premenstrual symptoms and their impact on everyday life during the luteal phase from baseline to post-treatment; Group differences in PMDD-related psychological and functional impairment during the luteal phase from baseline to post-treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.